Basit öğe kaydını göster

dc.contributor.authorAkagündüz, Baran
dc.contributor.authorAkın Telli, Tuğba
dc.contributor.authorGöksu, Sema Sezgin
dc.contributor.authorYıldırım, Hasan Çağrı
dc.contributor.authorÖzer, Muhammet
dc.contributor.authorGöktaş Aydın, Sabin
dc.contributor.authorÖzyurt, Neslihan
dc.contributor.authorKaracin, Cengiz
dc.contributor.authorPaydaş, Semra
dc.contributor.authorDoğan, Mutlu
dc.date.accessioned2021-03-25T07:26:49Z
dc.date.available2021-03-25T07:26:49Z
dc.date.issued2021en_US
dc.identifier.citationAkagündüz, B., Akın Telli, T., Göksu, S. S., Yıldırım, H. Ç., Özer, M., Göktaş Aydın, S. ... Doğan, M. (2021). Assessment of prognostic factors and adjuvant treatment modalities in adult head and neck soft tissue sarcoma patients treated with upfront surgery. Cureus, 13(2). https://dx.doi.org/10.7759/cureus.13324en_US
dc.identifier.issn2168-8184
dc.identifier.urihttps://dx.doi.org/10.7759/cureus.13324
dc.identifier.urihttps://hdl.handle.net/20.500.12511/6652
dc.description.abstractObjectivesHead and neck soft tissue sarcomas (HNSTSs) are a heterogeneous group of rare tumors. Surgical resection with negative margins remains the standard primary treatment for patients with HNSTS. The role of chemotherapy (CT) and radiotherapy (RT) remains controversial. In this multicenter study, we aimed to demonstrate the real-world assessing prognostic factors and the effect of adjuvant treatment modalities in adult patients with HNSTS treated with upfront surgery.MethodsWe included a total of 47 patients who underwent curative-intent resection of a primary HNSTS between 2000 and 2019.ResultsThe median follow-up was 29 months. The median age of patients was 51 years, and 66% of patients were male. The median relapse-free survival (RFS) of the study population was 31 months (range: 1.0-61.1 months), and the median overall survival (OS) was 115 months (range: 60.8-169.2 months). The univariable analysis revealed that treatment modalities showed a significant impact on RFS (p = 0.021); however, no difference was found in its impact on OS (p = 0.137). R0 resection did not showed impact on RFS (p = 0.130), but a significant association was found with OS (p = 0.004). In multivariable analysis, T stage of the tumor (hazard ratio [HR]: 3.834; 95% CI: 1.631-9.008; p = 0.002) and treatment with surgery and sequential RT and CT (HR: 0.115; 95% CI: 0.035-0.371; p < 0.001) were independent factors associated with RFS. R0 resection was independently associated with OS (HR: 4.902; 95% CI: 1.301-18.465; p = 0.019).ConclusionOur study revealed that R0 resection improved OS, and T3-4 stage of tumor was a negative independent factor for RFS in surgically resected HNSTS patients. The use of sequential CT and RT after resection was associated with a better RFS, which emphasizes the importance of multidisciplinary evaluation of the treatment of HNSTS. Randomized prospective studies are needed.en_US
dc.language.isoengen_US
dc.publisherCureus Inc.en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectSurvival Analysisen_US
dc.subjectHead and Neck Sarcomaen_US
dc.subjectAdjuvant Radiation Therapyen_US
dc.subjectHead and Neck Cancer Surgeryen_US
dc.subjectAdjuvant Chemotherapyen_US
dc.titleAssessment of prognostic factors and adjuvant treatment modalities in adult head and neck soft tissue sarcoma patients treated with upfront surgeryen_US
dc.typearticleen_US
dc.relation.ispartofCureusen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.identifier.volume13en_US
dc.identifier.issue2en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.7759/cureus.13324en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess